🇬🇧 MedBud.wiki
@MedBudUK
Followers
32K
Following
8K
Statuses
9K
Independent non-profit organisation tracking the #MedicalCannabis industry across the British Isles. We practice informed consent. @UKCanCouncil member.
🇬🇧🇮🇪🇯🇪🇬🇬🇮🇲
Joined August 2022
Our community forums launch today in BETA, with full mobile and desktop support - including push notifications: Email notification will be going out tomorrow. There's also greater integration into the main site to come. Our upcoming volunteer programme will also be launched via the forums, as well as final planning for the launch of patient reviews across the site 👍
14
11
46
@Matt_Hughes79 @darrensangita That's not really true, cultivars are important to all forms of derived cannabis medications as it informs on potential properties - and beyond that, cannabis is not a single chemical compound, but a conjunction of various cannabinoids and terpenes working together in tandem.
1
0
2
@darrensangita @Matt_Hughes79 Put it this way, you'll never stop patients using cultivar names to refer to different medications - and that's exactly what most doctors/clinicians are used to too.
0
0
2
RT @MedBudUK: @Matt_Hughes79 ^ for others reading, just to note there's numerous exceptions to the above. Only Schedule 2 (finished) flowe…
0
1
0
^ for others reading, just to note there's numerous exceptions to the above. Only Schedule 2 (finished) flower imports have to go through label approval, Schedule 1 (unfinished) bulk packagers in the UK don't need to have labels approved - but are otherwise expected to follow rules/regulations. As in, if they screw up, they could later be called up on it still - and that could cause a risk to their license. Further, some medications already registered within the EU often seem to bypass domestic requirements. For example meds from Germany still seem to get through no issue with cultivar names intact. Be that Aurora, Tilray, or many Cantourage offerings. Overall, we're still waiting on the MHRA to issue new clear and concise guidance which companies can depend on being uniformly applied across all medications.
0
1
4
RT @marclanders: @MedBudUK @RobertKennedyJr It's important to remember how the rescheduling process works under the law. The Health and Hu…
0
1
0
The world is watching to see how @RobertKennedyJr handles cannabis rescheduling in the 🇺🇸 US. There's the potential for America to finally start taking over the ever-maturing international legal cannabis market - 🇨🇦 Canada already has $150m+ of annual exports, $1b+ within years.
RFK Jr. has been Confirmed. Congratulations to our new Health and Human Services secretary.
1
2
14
RT @Matt_Hughes79: For or against cannabis cultivar nomenclature in medicine, it has no direct bearing to why patients in particular paedia…
0
3
0
RT @teamleafie: The mainstream media is well known for getting cannabis research wrong. Is sensationalism the reason NHS doctors are relu…
0
4
0
RT @MedBudUK: The @MHRAgovuk have been continuing to approve fake 1% CBD claims for flower meds. If CBD is registered as an active ingredi…
0
3
0
@darrensangita @cocoj69 @DeviateDefiant @CipheredReality Yes it does, the COAs produced whether 'final packaging' or 'bulk' are always post-remediation too.
0
0
0
To note, on all affected products - MedBud does not list 1% CBD publicly.
0
0
2
@Bigdoinks118685 We've heard similar claims, but nothing we can verify ourselves just yet through current importers.
1
0
0
@xrpye1 @cocoj69 @DeviateDefiant @CipheredReality Indeed, we checked their formulary earlier today - it should drastically improve over the coming days.
0
0
0
1
0
0
2
0
1